医学
嗜酸性粒细胞增多
多发性单神经炎
坏死性血管炎
血管炎
嗜酸性粒细胞增多症
系统性血管炎
结节性多动脉炎
肌痛
内科学
皮肤病科
胃肠病学
哮喘
疾病
作者
Loïc Guillevin,Pascal Cohen,M. Gayraud,François Lhote,Bernard Jarrousse,Philippe Casassus
出处
期刊:Medicine
[Wolters Kluwer]
日期:1999-01-01
卷期号:78 (1): 26-37
被引量:1120
标识
DOI:10.1097/00005792-199901000-00003
摘要
Churg-Strauss syndrome (CSS) is a systemic vasculitis characterized by the presence of asthma, hypereosinophilia, and necrotizing vasculitis with extravascular eosinophil granulomas. In this retrospective study of 96 patients between 1963 and 1995, we analyzed clinical manifestations, identified prognostic factors, and assessed the long-term outcome. CSS was diagnosed when asthma, hypereosinophilia > 1,500/mm3 or > 10%, and clinical manifestations consistent with systemic vasculitis, with or without histologic evidence, were present. Asthma was the most frequently observed manifestation at presentation, with mononeuritis multiplex the second. Other common manifestations were weight loss, fever, myalgia, skin involvement, paranasal sinusitis, arthralgia, pulmonary infiltrate, and gastrointestinal involvement. Mean eosinophilia at presentation was 7.193 +/- 6.706/mm3; ANCA, present in 20 of 42 (47.6%) patients, predominantly gave the perinuclear labeling pattern. All the patients were treated with corticosteroids alone or in combination with cyclophosphamide or plasma exchanges. Clinical remission was obtained in 91.5%; 22 (25.6%) patients relapsed. Twenty-three patients died during follow-up: 11 of these deaths were directly due to vasculitis. The presence of severe gastrointestinal tract or myocardial involvement was significantly associated with a poor clinical outcome. The long-term prognosis of CSS is good and does not differ from that of polyarteritis nodosa, although most patients need low doses of oral corticosteroids for persistent asthma, even many years after clinical recovery from vasculitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI